Valneva SE (ADR) Live Stock Price Today, Share Analysis and Chart

Name: Valneva SE - ADR: Is Infosys Ltd. worth buying?
Item: Valneva SE - ADR
Rating: 1.04579175
Author: Trendlyne DVM scores

Weak Stock

about

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESP...

5.93 0.06 (1.02%)

51.59% Fall from 52W High

38,070.6

XNAS Volume

XNAS 14 May, 2026 1:40 PM (EDT)

Board Meeting

The latest board meeting for Valneva SE (ADR) took place on 13 May 2026, for the purpose of Valneva SE First Quarter Earnings Result for 2026 See details

Low Financial Strength

16.7 / 100

Expensive Valuation

19.5 / 100

Technically Bearish

30.8 / 100

Weak Stock These stocks have poor scores across the board. Investors should be very cautious with these stocks View Similar Embed DVM

1Yr Price target upside is 106%

4 analysts

Valneva SE (ADR) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..